Unknown

Dataset Information

0

Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer.


ABSTRACT: We showed previously that in early-stage non-small-cell lung cancer (NSCLC), serum vitamin D levels and VDR polymorphisms were associated with survival. We hypothesized that vitamin D levels and VDR polymorphisms may also affect survival among patients with advanced NSCLC.We evaluated the relationship between circulating 25-hydroxyvitamin D levels; VDR polymorphisms, including Cdx-2 G>A (rs11568820), FokI C>T (rs10735810), and BsmI C>T (rs144410); and overall survival among patients with advanced NSCLC. Analyses of survival outcomes were performed using the log-rank test and Cox proportional hazards models, adjusting for sex, stage, and performance status.There were 294 patients and 233 deaths, with median follow-up of 42 months. We found no difference in survival by circulating vitamin D level. The C/C genotype of the FokI polymorphism was associated with improved survival: median survival for C/C was 21.4 months, for C/T was 12.1 months, and for T/T was 15.6 months (log-rank P = .005). There were no significant effects on survival by the Cdx-2 or BsMI polymorphism. However, having increasing numbers of protective alleles was associated with improved survival (adjusted hazard ratio for two or more v zero to one protective alleles, 0.57; 95% CI, 0.41 to 0.79; P = .0008). On haplotype analysis, the G-T-C (Cdx-2-FokI-BsmI) haplotype was associated with worse survival compared with the most common haplotype of G-C-T (adjusted hazard ratio, 1.61; 95% CI, 1.21 to 2.14; P = .001).There was no main effect of vitamin D level on overall survival in the advanced NSCLC population. The T allele of the VDR FokI>T polymorphism and the G-T-C (Cdx-2-FokI-BsmI) haplotype were associated with worse survival.

SUBMITTER: Heist RS 

PROVIDER: S-EPMC2651100 | biostudies-literature | 2008 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer.

Heist Rebecca Suk RS   Zhou Wei W   Wang Zhaoxi Z   Liu Geoffrey G   Neuberg Donna D   Su Li L   Asomaning Kofi K   Hollis Bruce W BW   Lynch Thomas J TJ   Wain John C JC   Giovannucci Edward E   Christiani David C DC  

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081020 34


<h4>Purpose</h4>We showed previously that in early-stage non-small-cell lung cancer (NSCLC), serum vitamin D levels and VDR polymorphisms were associated with survival. We hypothesized that vitamin D levels and VDR polymorphisms may also affect survival among patients with advanced NSCLC.<h4>Patients and methods</h4>We evaluated the relationship between circulating 25-hydroxyvitamin D levels; VDR polymorphisms, including Cdx-2 G>A (rs11568820), FokI C>T (rs10735810), and BsmI C>T (rs144410); and  ...[more]

Similar Datasets

| S-EPMC3378514 | biostudies-literature
| S-EPMC4526455 | biostudies-literature
| S-EPMC10338177 | biostudies-literature
| S-EPMC5690785 | biostudies-literature
| S-EPMC4089671 | biostudies-other
| S-EPMC5715727 | biostudies-literature
| S-EPMC7211036 | biostudies-literature
| S-EPMC4155431 | biostudies-other
| S-EPMC3776984 | biostudies-other
| S-EPMC3524394 | biostudies-literature